Alzheimer disease trials in Canada

In Canada 58 Also abroad 822

14 of 58 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
A Post Authorization Registry Study of Participants Treated With LEQEMBI
Where
Calgary, Edmonton, Gatineau, Greenfield Park, Kingston, London, Mississauga, Montreal, Ottawa, Peterborough, Québec, Toronto, Vancouver, Victoria
People
400
Run by
Eisai Limited
See details and how to joinNCT07762092
No phaseEnrolling by invitation
BioMIND Biospecimen Repository
Where
London
Age
18 years and over
People
1,000
Run by
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT07912736
No phaseNot yet taking people in Canada
Remote Digital Assessments for Cognitive Disorders
Where
Toronto
Age
50 years and over
People
60
Run by
Centre for Addiction and Mental Health
See details and how to joinNCT07883746
No phaseTaking people
Development of Eye-movement Based Biomarkers in Alzheimer's Disease
Where
Montreal, Ville-Marie
Age
18 years and over
People
250
Run by
McGill University
See details and how to joinNCT05176704
No phaseNot yet taking people in Canada
Dominantly Inherited Alzheimer Network (DIAN)
Where
Verdun
Age
18 years and over
People
700 worldwide
Run by
Washington University School of Medicine
See details and how to joinNCT00869817
No phaseEnrolling by invitation
Alzheimer's Disease Neuroimaging Initiative 4
Where
London, Toronto, Vancouver
Age
55 years to 90 years
People
1,500 worldwide
Run by
University of Southern California
See details and how to joinNCT05617014
No phaseTaking people
Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
Where
Toronto
Age
60 years to 90 years
People
1,200 worldwide
Run by
GAP Innovations, PBC
See details and how to joinNCT06584357
No phaseTaking people
Comprehensive Assessment of Neurodegeneration and Dementia
Where
Calgary, Edmonton, Halifax, Hamilton, London, Montreal, Ottawa, Peterborough, Québec, Sherbrooke, Toronto, Vancouver, Victoria, Waterloo
Age
50 years to 90 years
People
1,573
Run by
McGill University
See details and how to joinNCT03402919
No phaseTaking people
Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling
Where
North York, Toronto
Age
30 years to 95 years
People
500
Run by
University Health Network, Toronto
See details and how to joinNCT06529744
No phaseTaking people
Screening for Anti-amyloid Treatment Eligibility Using Digital Cognition and Blood-based Biomarkers
Where
Greenfield Park
Age
55 years to 90 years
People
500
Run by
MoCA Clinic and Institute
See details and how to joinNCT07041450
No phaseTaking people
Investigating Genetic Status in Patients Presenting to Clinic
Where
London
Age
18 years and over
People
1,000
Run by
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT05911932
No phaseEnrolling by invitation
Biomarkers in a Candian Memory Clinic
Where
London
Age
55 years to 80 years
People
100
Run by
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT06843109
No phaseTaking people
Assessing the Impact of DAy Programs on Individuals Living with Dementia and Their Family/friend Caregivers
Where
Edmonton & Calgary, Multiple, Winnipeg
Age
65 years and over
People
3,000
Run by
York University
See details and how to joinNCT06496945
No phaseTaking people
Gait as Predictor of Dementia and Falls. The Gait and Brain Cohort Study
Where
London
Age
60 years to 85 years
People
600
Run by
Manuel Montero Odasso
See details and how to joinNCT03020381